{
  "meta": {
    "title": "24_Hemochromatosis_And_Wilson_S_Disease",
    "url": "https://brainandscalpel.vercel.app/24-hemochromatosis-and-wilson-s-disease-7ca72afc.html",
    "scrapedAt": "2025-11-30T12:28:32.351Z"
  },
  "questions": [
    {
      "text": "What is the most common gene mutation associated with hemochromatosis?",
      "choices": [
        {
          "id": 1,
          "text": "H49D"
        },
        {
          "id": 2,
          "text": "C282Y"
        },
        {
          "id": 3,
          "text": "G97C"
        },
        {
          "id": 4,
          "text": "A480H"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common mutation seen in hemochromatosis is&nbsp;a <strong>cysteine to tyrosine</strong> substitution at position <strong>282 </strong>(<strong>C282Y</strong>) in the&nbsp;<strong>HFE </strong>gene.</p>\n<p>HFE mutations are the most common cause of hereditary hemochromatosis and are inherited as an<strong> autosomal recessive </strong>trait.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7180",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions are unlikely to develop iron overload?",
      "choices": [
        {
          "id": 1,
          "text": "Sideroblastic anemia"
        },
        {
          "id": 2,
          "text": "Non-alcoholic steatohepatitis"
        },
        {
          "id": 3,
          "text": "Porphyria cutanea tarda"
        },
        {
          "id": 4,
          "text": "Thalassemia minor"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Thalassemia minor does not result in iron overload. <strong>Secondary hemochromatosis </strong>or<strong> iron overload</strong> is characterized by the deposition of iron in parenchymal cells.</p><hr><h3>Related Pearl: Classification of Iron Overload</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Primary / Hereditary Hemochromatosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>HFE gene-related</strong></p>\n<ul>\n<li>Type 1: C282Y mutations of genes encoding HFE&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Non-HFE gene-related</strong></p>\n<ul>\n<li>Type 2: Juvenile hemochromatosis\n<ul>\n<li>2a <strong>- </strong>HJV&nbsp;mutation (hemojuvelin)</li>\n<li>2b<strong> - </strong>HAMP mutation (Hepcidin)</li>\n</ul>\n</li>\n<li>Type 3: Transferrin receptor 2 (TfR2) related&nbsp;</li>\n<li>Type 4<strong>:&nbsp;</strong>Ferroportin-related HH&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secondary / Acquired Hemochromatosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Transfusion iron overload</strong></p>\n<ul>\n<li>Thalassemia major</li>\n<li>Sideroblastic anemia</li>\n<li>Chronic hemolytic anemias</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chronic liver disease</strong></p>\n<ul>\n<li>Alcoholic liver disease</li>\n<li>Non-alcoholic steatohepatitis (NASH)</li>\n<li>Porphyria cutanea tarda</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 3023\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Miscellaneous</strong></p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>Congenital atransferrinemia</li>\n<li>African iron overload (Bantu siderosis)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7182",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following clinical manifestations of hemochromatosis is incorrectly matched with its mechanism of onset?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Clinical feature</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>1. </td>\n<td>Hypothyroidism - </td>\n<td>Iron deposition in pituitary</td>\n</tr>\n<tr>\n<td>2. </td>\n<td>Arthropathy - </td>\n<td>Deposition of calcium pyrophosphate crystals</td>\n</tr>\n<tr>\n<td>3. </td>\n<td>Skin hyperpigmentation - </td>\n<td>Increased melanin production</td>\n</tr>\n<tr>\n<td>4. </td>\n<td>Sexual dysfunction - </td>\n<td>Iron deposition in testes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sexual dysfunction</strong> (decreased libido, impotence, amenorrhea) in <strong>hemochromatosis</strong> occurs as a result of <strong>hypogonadotropic hypogonadism</strong>. This is due to iron deposition in the <strong>pituitary</strong> gland, not testes.</p>\n<p><strong>Iron deposition</strong> occurs in the following sites:  </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Organ</strong></td>\n<td><strong>Manifestation</strong></td>\n</tr>\n<tr>\n<td>Liver</td>\n<td>Hepatomegaly</td>\n</tr>\n<tr>\n<td>Skin</td>\n<td>\n<p>Slate-grey or bronze skin hyperpigmentation: <strong>increased melanin synthesis </strong>due to iron deposition</p>\n</td>\n</tr>\n<tr>\n<td>Pancreas</td>\n<td>pancreatic diabetes/type 3C diabetes</td>\n</tr>\n<tr>\n<td><strong>Pituitary</strong></td>\n<td>\n<p>Hypogonadotropic hypogonadism</p>\n<p>Secondary hypothyroidism</p>\n</td>\n</tr>\n<tr>\n<td>Heart</td>\n<td>\n<p>Dilated cardiomyopathy</p>\n<p>Congestive heart failure</p>\n<p>Arrhythmias</p>\n</td>\n</tr>\n<tr>\n<td>Joints</td>\n<td>\n<p>Arthropathy is due to:</p>\n<ul>\n<li>Iron deposition</li>\n<li>Calcium pyrophosphate deposition (<strong>pseudogout</strong>)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7187",
      "difficulty": "medium"
    },
    {
      "text": "A 7-year-old boy undergoes genetic testing as his brother has been diagnosed with hereditary hemochromatosis. He is found to be homozygous for the C282Y mutation. Which of the following is the strongest indicator that he will develop symptoms of the disease?",
      "choices": [
        {
          "id": 1,
          "text": "Plasma iron >180 µg/dL"
        },
        {
          "id": 2,
          "text": "Total iron binding capacity >200 µg/dL"
        },
        {
          "id": 3,
          "text": "Transferrin saturation >50%"
        },
        {
          "id": 4,
          "text": "Serum ferritin level >1000 μg/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Serum<strong> ferritin</strong><strong>&nbsp;&gt; 1000 </strong>&mu;g/L is the <strong>strongest</strong> <strong>predictor</strong> of disease expression among individuals homozygous for the <strong>C282Y</strong> mutation.&nbsp;</p>\n<p>Many patients with C282Y mutations are <strong>initially asymptomatic</strong> and do not show features of iron overload. In such patients, serum ferritin can indicate whether they are likely to develop the disease as ferritin levels reflect&nbsp;the total iron stores.&nbsp;</p>\n<p>As ferritin levels may be high following inflammatory conditions, combined measurement of <strong>ferritin</strong> and <strong>transferrin saturation</strong> is done in a <strong>practical</strong> setting to avoid false positives. It is also repeated once inflammation subsides. If these tests are abnormal, genetic testing for HFE mutations is done.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7189",
      "difficulty": "medium"
    },
    {
      "text": "A 47-year-old diabetic man is worried as the skin over his face, neck, and dorsum of hands has turned greyish over the past two months. He also complains of abdominal and joint pain. On examination, gynecomastia and hepatomegaly are noted. What is the treatment of choice for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Phlebotomy"
        },
        {
          "id": 2,
          "text": "Deferoxamine"
        },
        {
          "id": 3,
          "text": "Deferasirox"
        },
        {
          "id": 4,
          "text": "Liver transplantation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical scenario is suggestive of <strong>hemochromatosis</strong>. The <strong>treatment of choice</strong> is the removal of excess iron by <strong>phlebotomy.</strong></p>\n<p>Phlebotomy is an<strong>&nbsp;</strong>inexpensive,&nbsp;convenient, and safe&nbsp;method of treatment.&nbsp;In this process, <strong>500 mL</strong> of blood is removed 1-2 times weekly which removes&nbsp;200-250 mg of iron.&nbsp;<strong>Weekly</strong> phlebotomy should be continued until the serum <strong>ferritin</strong> level is <strong>&le;100&nbsp;&mu;g/L</strong> and every <strong>3 months</strong>&nbsp;thereafter. It is <strong>contraindicated</strong> in severe <strong>anemia</strong> and <strong>hypoproteinemia</strong>.</p>\n<p><strong>Chelating agents</strong>&nbsp;bind to iron to form complexes that get excreted and are the <strong>drugs of choice</strong>. Drugs such as <strong>deferoxamine</strong> and <strong>deferasirox</strong> are commonly used. However, they&nbsp;are less effective and more expensive than&nbsp;phlebotomy.</p>\n<p dir=\"ltr\" role=\"presentation\"><strong>Liver transplantation</strong>&nbsp;is indicated either in end-stage liver disease or in refractory cases.</p>\n<p><strong>Supportive management</strong> includes avoiding iron-containing substances such as red meat, multi-vitamin tablets, etc. Alcohol should be completely avoided as it can aggravate the disease.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7191",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old man with hereditary hemochromatosis has been started on weekly phlebotomy. All of the following features will improve with this treatment except:",
      "choices": [
        {
          "id": 1,
          "text": "Hepatomegaly"
        },
        {
          "id": 2,
          "text": "Skin pigmentation"
        },
        {
          "id": 3,
          "text": "Cardiac failure"
        },
        {
          "id": 4,
          "text": "Arthropathy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In hemochromatosis, removal of excess iron through phlebotomy has<strong> no effect </strong>on<strong> arthropathy </strong>and<strong> hypogonadism</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7193",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrect about Wilson's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Gain-of-function mutation of ATP7B"
        },
        {
          "id": 2,
          "text": "AP1S1 gene is essential for normal functioning"
        },
        {
          "id": 3,
          "text": "Siblings of affected children have 1 in 4 risk of the disease"
        },
        {
          "id": 4,
          "text": "Mutation on chromosome 13"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Wilson&rsquo;s disease is caused due to a <strong>loss-of-function mutation</strong> in the <strong>ATP7B</strong> gene on <strong>Chr.13q</strong>. The gene encodes a copper transporting ATPase (ATP7B) which has 2 functions:</p>\n<ul>\n<li aria-level=\"1\">Maintains copper in bound form by binding copper to apoceruloplasmin</li>\n<li aria-level=\"1\">Helps excrete free copper in bile.</li>\n</ul>\n<p>Thus, an ATP7B deficiency leads to <strong>excess deposition of free copper</strong> within tissues.&nbsp;It is an <strong>autosomal recessive</strong> condition. So, siblings of affected children have a <strong>1 in 4</strong> chance.</p>\n<p><strong>Intracellular trafficking</strong> of ATP7B (Wilson's disease) and ATP7A (Menke's disease) genes are regulated by an adaptor protein encoded by the&nbsp;<strong>AP1S1</strong> gene. Mutations in this gene result in a syndrome with features of both Wilson's and Menke's diseases. It is called <strong>MEDNIK syndrome</strong>:</p>\n<ul>\n<li>Mental retardation</li>\n<li>Enteropathy</li>\n<li>Deafness</li>\n<li>Neuropathy</li>\n<li>Ichthyosis</li>\n<li>Keratodermia.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2512",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are true regarding KF ring?<div class='question-desc-html'><ol>\n<li>Seen in all patients with neurological involvement</li>\n<li>Is seen only for Wilson's disease</li>\n<li>Resolves with desferrioxamine</li>\n<li>Seen in all patients with hepatic involvement</li>\n<li>Seen in superior and inferior pole of Descemet's membrane</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 5 only"
        },
        {
          "id": 2,
          "text": "1 and 5 only"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4 and 5"
        },
        {
          "id": 4,
          "text": "2, 3, 4 and 5 only"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the given options only <strong>statements 1 and 5 are true. </strong></p>\n<p><strong>Kayser-Fleischer (KF) rings</strong> are seen in almost all patients of <strong>Wilson's disease</strong> with neurological involvement. It initially appears as a <strong>crescent</strong> in the superior pole of <strong>Descemet's membrane</strong> and gradually extends inferiorly, eventually becoming <strong>circumferential</strong> in shape.</p>\n<p>KF rings occur due to <strong>copper</strong> deposition in the descemet's membrane. It is golden-brown to greenish-brown in color and can be best seen by <strong>slit-lamp</strong> examination.</p>\n<p>The image below shows a KF ring :&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af5e1b00249b45648917b1cc46d266bfx720x632.PNG\" alt=\"Explanation Image\"><p>While it is a characteristic sign of Wilson&rsquo;s disease (<strong>statement 2</strong>), it can also be seen in:&nbsp;</p>\n<ul>\n<li>Primary biliary cholangitis</li>\n<li>Primary sclerosing cholangitis</li>\n<li>Cholestasis</li>\n</ul>\n<p>KF rings are present in almost <strong>95% </strong>of patients of Wilson's disease with neurological/psychiatric symptoms compared to around 65% of those with hepatic presentations<strong> (statement 4).</strong></p>\n<p>They <strong>disappear</strong> on treatment with <strong>copper-chelating agents</strong> like <strong>d-penicillamine </strong>(while desferrioxamine is an iron chelating agent) and <strong>reappear</strong> with disease progression<strong> (statement 3).</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6956",
      "difficulty": "medium"
    },
    {
      "text": "In patients with Wilson's disease, Kayser-Fleischer rings are most commonly associated with:",
      "choices": [
        {
          "id": 1,
          "text": "Hepatitis"
        },
        {
          "id": 2,
          "text": "Dystonia"
        },
        {
          "id": 3,
          "text": "Osteoarthritis"
        },
        {
          "id": 4,
          "text": "Cholelithiasis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of the&nbsp;<strong>Kayser-Fleischer</strong> (KF) ring in <strong>Wilson's disease</strong>&nbsp;is most commonly associated with&nbsp;<strong>neuropsychiatric</strong> manifestations such as&nbsp;<strong>dystonia.</strong></p>\n<p>In majority of the cases, neuropsychiatric manifestations follow hepatic manifestations. It is due to the <strong>deposition </strong>of&nbsp;<strong>free copper</strong> in the <strong>basal ganglia</strong> (leading to bilateral degeneration and atrophy) and <strong>cortex</strong>. The features include:</p>\n<ul>\n<li><strong>Dysarthria</strong> (most common): Irregular word spacing, hypophonic or spastic speech</li>\n<li><strong>Dystonia</strong>: Vacuous smile i.e mask-like face with an open mouth</li>\n<li><strong>Parkinsonism: </strong>Bradykinesia, postural instability, rigidity</li>\n<li><strong>Subcortical dementia</strong>: Slow mental processing, memory loss</li>\n<li>Psychiatric symptoms: Loss of emotional control, depression, hyperactivity</li>\n<li>Decreased scholastic performance: Deterioration in handwriting, clumsiness</li>\n<li>Autonomic symptoms: Excessive sweating and salivation, sexual dysfunction</li>\n<li><strong>Wing beating tremors</strong> (seen in advanced disease): High amplitude tremor that is prominent with arms abducted, elbows flexed and palms facing downward.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7199",
      "difficulty": "medium"
    },
    {
      "text": "A 22-year-old woman is being evaluated in the emergency department for a 3-day history of dark-colored urine and abdominal distension. On examination, she is conscious and oriented. Icterus is present. The following investigations are done. Which of the following would you suspect?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Hemoglobin</td>\n<td>9.2 g/dl</td>\n</tr>\n<tr>\n<td>Hematocrit</td>\n<td>26%</td>\n</tr>\n<tr>\n<td>Reticulocytes</td>\n<td>5%</td>\n</tr>\n<tr>\n<td>Platelets</td>\n<td>1.3 x 10<sup>5</sup>/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td>Serum total iron</td>\n<td>Reduced</td>\n</tr>\n<tr>\n<td>Serum ferritin</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Serum ALT</td>\n<td>110 IU/L</td>\n</tr>\n<tr>\n<td>Serum AST</td>\n<td>240 IU/L</td>\n</tr>\n<tr>\n<td>Serum ALP</td>\n<td>30 IU/L</td>\n</tr>\n<tr>\n<td>Total bilirubin</td>\n<td>13 mg/dl</td>\n</tr>\n<tr>\n<td>Anti-Hbs IgG</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>USG Abdomen</td>\n<td>Nodular liver and enlarged spleen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Hemochromatosis"
        },
        {
          "id": 2,
          "text": "Acute viral hepatitis"
        },
        {
          "id": 3,
          "text": "Primary biliary cirrhosis"
        },
        {
          "id": 4,
          "text": "Wilson's disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given laboratory values indicate <strong>hepatic</strong> disease and <strong>hemolytic</strong> <strong>anemia </strong>(low Hb with high reticulocyte count). These lab findings along with clinical features point to a diagnosis of <strong>Wilson's disease.</strong></p>\n<p>The clinical features of Wilson’s disease include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>System</strong></td>\n<td><strong>Clinical features</strong></td>\n</tr>\n<tr>\n<td>Hepatic<br />(most common)</td>\n<td>\n<p><span>Jaundice</span><br /><span>Abdominal pain</span><br /><span>Hepatomegaly</span><br /><span>Fatigue</span><br /><span>Ascites</span><br /><span>Variceal bleed</span><br /><span>Coagulation defects</span></p>\n<p><span>High AST &amp; ALT with low ALP</span></p>\n</td>\n</tr>\n<tr>\n<td>Neurological</td>\n<td>Dysarthria<br />Dystonia<br />Parkinsonism<br />Subcortical dementia<br />Depression<br />Wing beating tremors<br />Decreased scholastic performance</td>\n</tr>\n<tr>\n<td>Ophthalmic</td>\n<td>Kayser-Fleischer (KF) rings<br />Sunflower cataract</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>Hemolytic anemia (Coombs negative)<br />Acute pancreatitis<br />Fanconi's syndrome<br />Hyperparathyroidism<br />Cardiomyopathy<br />Spontaneous abortions<br />Infertility</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Option A: <strong>Hemochromatosis</strong> presents with clinical features of <strong>iron overload</strong>. Serum ferritin and total iron are elevated.</p>\n<p>Option B: <strong>Acute viral hepatitis</strong> presents with positive HbsAg, whereas anti-Hbs IgG indicates past infection. There is tender hepatomegaly with <strong>very high levels of transaminases</strong> (&gt;1000 IU/L).</p>\n<p>Option C: <strong>Primary biliary cirrhosis</strong> presents with jaundice, <strong>severe itching</strong>, and pale stools. There are <strong>high</strong> levels of direct bilirubin, <strong>ALP</strong>, and<strong> positive anti-mitochondrial antibodies.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7197",
      "difficulty": "medium"
    },
    {
      "text": "A child presents with hepatitis and progressive neurological degeneration. A picture of his eye has been provided below. Among the following options, what would be the initial step regarding the investigations done for this child's diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Serum ceruloplasmin levels"
        },
        {
          "id": 2,
          "text": "Serum copper levels"
        },
        {
          "id": 3,
          "text": "Enzyme assay"
        },
        {
          "id": 4,
          "text": "Karyotyping"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical features of <strong>hepatitis</strong>, <strong>progressive neurological degeneration,</strong> and the <strong>Kayser-Fleischer</strong> <strong>(KF)</strong> <strong>ring</strong> seen in the image are suggestive of <strong>Wilson's disease</strong>. The <strong>initial step</strong> regarding investigations done for the diagnosis is the measurement of <strong>serum ceruloplasmin levels</strong>.</p>\n<p><strong>Kayser-Fleischer (KF) ring</strong> is a golden to greenish-brown ring of deposition of <strong>copper</strong> in the <strong>Descemets membrane</strong> of the <strong>peripheral cornea</strong>. Patients with neurological manifestations manifest with KF ring in &gt;95% of cases.</p>\n<p class=\"p1\">Lab investigations in Wilson's disease would show:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Lab markers</strong></td>\n<td><strong>Change in Wilson's disease</strong></td>\n<td><strong>Reason</strong></td>\n</tr>\n<tr>\n<td><strong>Serum ceruloplasmin</strong></td>\n<td>&darr;&darr;&darr;</td>\n<td>ATP7B deficiency results in reduced bound copper</td>\n</tr>\n<tr>\n<td>24h urinary copper</td>\n<td>&uarr;&uarr;&nbsp; (&gt;100 &mu;g/24h)&nbsp;</td>\n<td>Excess free copper excreted in urine</td>\n</tr>\n<tr>\n<td>Total serum copper</td>\n<td>&darr;</td>\n<td>Due to marked reduction in ceruloplasmin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The <strong>gold standard</strong> technique for diagnosis of Wilson&rsquo;s disease is percutaneous needle <strong>liver biopsy</strong> for measurement of <strong>hepatic copper levels &gt;200 &mu;g/g</strong> of dry weight.</p><p>Option B: The role of total <strong>serum copper</strong> in the diagnosis of <strong>Wilson's</strong> disease is <strong>limited</strong>. Measurement of serum ceruloplasmin and urinary copper is preferred.</p>\n<p>Option C: <strong>ATP7B enzyme assays</strong> have shown promise in early studies as a <strong>neonatal screening test</strong> for Wilson's disease. However, it is <strong>not</strong> yet part of <strong>routine</strong> clinical practice.</p>\n<p>Option D: <strong>Karyotyping</strong> is done for every <strong>asymptomatic</strong> 1st and 2nd degree relative of a patient with Wilson&rsquo;s disease. This helps <strong>differentiate</strong> the <strong>carriers (heterozygous)</strong> from the <strong>patients (homozygous)</strong> and can lead to early initiation of treatment before the onset of symptoms.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/eb23fc76116647f2b380907ac0e35b62.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2501",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following findings would be seen in a patient with Wilson's disease?<div class='question-desc-html'><ol>\n<li>Decreased total serum copper</li>\n<li>Increased total serum copper</li>\n<li>Decreased serum ceruloplasmin</li>\n<li>Increased urinary copper</li>\n<li>Decreased free serum copper</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3, 4"
        },
        {
          "id": 2,
          "text": "1, 3, 4"
        },
        {
          "id": 3,
          "text": "2, 4, 5"
        },
        {
          "id": 4,
          "text": "2, 3, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The following findings will be seen in a patient with Wilson's disease:</p>\n<ul>\n<li>Decreased total serum copper</li>\n<li>Decreased serum ceruloplasmin</li>\n<li>Increased urinary copper</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Lab markers</strong></td>\n<td><strong>Change in Wilson's disease</strong></td>\n<td><strong>Reason</strong></td>\n</tr>\n<tr>\n<td>Serum ceruloplasmin</td>\n<td>&darr;&darr;&darr;</td>\n<td>ATP7B deficiency results in reduced bound copper</td>\n</tr>\n<tr>\n<td>24h urinary copper</td>\n<td>&uarr;&uarr;</td>\n<td>Excess free copper excreted in urine</td>\n</tr>\n<tr>\n<td>Total serum copper</td>\n<td>&darr;</td>\n<td>Due to marked reduction in ceruloplasmin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Normally, &gt;90% of copper exists in bound form and &lt;10% in free form. In Wilson&rsquo;s disease, despite elevated levels of free copper, the marked reduction in ceruloplasmin results in a net reduction of total serum copper i.e.,</p>\n<p>&darr;total serum copper =&uarr;free copper + &darr;&darr;ceruloplasmin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2510",
      "difficulty": "easy"
    },
    {
      "text": "A 15-year-old boy is brought with complaints of abnormal posture. His scholastic performance used to be above average but has deteriorated over the last 3 months. Dystonia and increased muscle tone are noted on clinical examination. The following picture is seen on ophthalmic examination. What is the gold standard for the diagnosis of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Serum copper"
        },
        {
          "id": 2,
          "text": "Serum ceruloplasmin"
        },
        {
          "id": 3,
          "text": "Urinary copper"
        },
        {
          "id": 4,
          "text": "Liver copper"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This clinical scenario and image showing Kayser-Fleischer (<strong>KF</strong>) <strong>ring</strong> with <strong>sunflower</strong> <strong>cataract</strong> are suggestive of<strong>&nbsp;Wilson's</strong> disease.<strong>&nbsp;</strong>The <strong>gold standard</strong> for diagnosis&nbsp;is the estimation of&nbsp;<strong>liver copper&nbsp;</strong>following biopsy.</p>\n<p>A copper level of <strong>&gt;200 &mu;g/g</strong> dry liver tissue is diagnostic for Wilson's disease. It is measured using neutron activation analysis or atomic absorption spectrometry.&nbsp;</p>\n<p><strong>Sunflower cataract</strong> is a rare finding of Wilson&rsquo;s disease. It occurs due to the <strong>deposition of copper</strong> in the center of the <strong>lens</strong>.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/41dc0459eb9d4723bd1a642607366813.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7204",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist is preparing a tissue sample from the liver biopsy of a patient with Wilson's disease. What stain will he use?",
      "choices": [
        {
          "id": 1,
          "text": "Perl stain"
        },
        {
          "id": 2,
          "text": "Rubeanic acid"
        },
        {
          "id": 3,
          "text": "Supravital stain"
        },
        {
          "id": 4,
          "text": "Schmorl’s method"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In&nbsp;<strong>Wilson&rsquo;s disease,</strong>&nbsp;liver biopsy samples are stained using&nbsp;<strong>rubeanic acid&nbsp;</strong>to visualize the&nbsp;<strong>cytoplasmic copper</strong>.&nbsp;</p>\n<p>Another stain used for copper is the <strong>rhodanine</strong> stain.&nbsp;However, copper staining is <strong>not reliable</strong> for diagnosis and a quantitative copper assay must be performed.</p>\n<p>The given image shows the staining of copper by rubeanic acid.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c1cf4ceffb114fc8ba6b1e72116bc007x800x600.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7196",
      "difficulty": "medium"
    },
    {
      "text": "A 17-year-old girl was brought with involuntary, writhing movements of her limbs. On examination, she is anicteric with dystonia and hyperreflexia. Investigations revealed mildly elevated transaminases and low serum ceruloplasmin levels. Which of the following is the safest drug that can be initiated for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Zinc"
        },
        {
          "id": 2,
          "text": "D-Penicillamine"
        },
        {
          "id": 3,
          "text": "Trientine"
        },
        {
          "id": 4,
          "text": "Tetrathiomolybdate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This<strong>&nbsp;</strong>clinical scenario is suggestive of <strong>Wilson's disease</strong> with predominantly <strong>neurological features.</strong> The&nbsp;<strong>safest&nbsp;</strong>drug that can be initiated for this patient is <strong>trientine</strong>. This is because D-penicillamine can worsen neurological symptoms and would not be tolerated by this patient.</p>\n<p>The copper chelating agents,<strong>&nbsp;D-penicillamine</strong> and <strong>trientine</strong> are the <strong>first-line</strong> drugs in the management of Wilson's disease. <strong>D-penicillamine</strong> is the <strong>recommended</strong> drug due to its availability and cost-effectiveness compared to trientine.</p>\n<p>However, <strong>D-penicillamine</strong> can precipitate various <strong>adverse effects</strong> including aplastic anemia, myasthenia gravis and membranous nephropathy. It can also <strong>worsen neurologica</strong>l symptoms. Hence, <strong>trientine </strong>is administered&nbsp;in those who <strong>cannot tolerate D-penicillamine</strong>.</p>\n<p>Elemental <strong>zinc</strong> is commonly used as a <strong>maintenance</strong> therapy along with chelating agents. It can also be used as <strong>first-line</strong> therapy in <strong>pregnancy</strong>.</p>\n<p><strong>Tetrathiomolybdate</strong> is currently under phase 2 <strong>clinical trials</strong>. It has been identified to be effective in patients with neuropsychiatric manifestations but is not approved for clinical use.</p>\n<p>Liver transplantation is the definitive treatment for advanced liver disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7213",
      "difficulty": "hard"
    },
    {
      "text": "For a patient with Wilson's disease, you would administer pyridoxine along with which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Zinc"
        },
        {
          "id": 2,
          "text": "Penicillamine"
        },
        {
          "id": 3,
          "text": "Trientine"
        },
        {
          "id": 4,
          "text": "Tetrathiomolybdate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Penicillamine</strong> should always be co-administered with <strong>pyridoxine</strong> (25 mg/day) as it is an antagonist to pyridoxine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7209",
      "difficulty": "medium"
    },
    {
      "text": "The Nazer’s prognostic index for Wilson’s disease includes all of the following parameters except:",
      "choices": [
        {
          "id": 1,
          "text": "Serum bilirubin"
        },
        {
          "id": 2,
          "text": "AST"
        },
        {
          "id": 3,
          "text": "ALT"
        },
        {
          "id": 4,
          "text": "Prothrombin time"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>ALT is not a part of <strong>Nazer&rsquo;s</strong> prognostic index.&nbsp;</p>\n<p>Nazer&rsquo;s prognostic index&nbsp;is used to establish disease severity in Wilson&rsquo;s disease patients who present with hepatic decompensation.</p><hr><h3>Related Pearl: Nazer’s Prognostic Index</h3><p><strong>Nazer&rsquo;s prognostic index</strong> for <strong>Wilson&rsquo;s disease</strong></p>\n<ul>\n<li>Serum bilirubin</li>\n<li>Serum aspartate aminotransferase (AST)</li>\n<li>Prolongation of prothrombin time (sec)</li>\n</ul>\n<p>Interpretation of Scores :</p>\n<ul>\n<li>&lt; 7 &ndash; Medical therapy</li>\n<li>7&ndash;9 &ndash; Clinical judgement, Either medical / surgical treatment</li>\n<li>&gt; 9 &ndash; Liver transplantation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7206",
      "difficulty": "medium"
    },
    {
      "text": "Low serum copper levels attributed to ATP7A gene is due to:",
      "choices": [
        {
          "id": 1,
          "text": "Dubin-Johnson syndrome"
        },
        {
          "id": 2,
          "text": "Wilson's disease"
        },
        {
          "id": 3,
          "text": "Menke's disease"
        },
        {
          "id": 4,
          "text": "Gilbert's syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Low serum copper</strong> level attributed to the <strong>ATP7A gene</strong> is due to <strong>Menke's disease&nbsp;</strong>(Option C).</p>\n<p>Menke's disease or Menke-Kinky hair syndrome is an <strong>X-linked recessive</strong> condition occurring due to a mutation in the <strong>ATP7A gene</strong> on <strong>chromosome X</strong>. This causes <strong>impaired transport</strong> of <strong>dietary copper</strong> from the <strong>small intestine</strong> to the <strong>liver</strong> leading to low levels of copper-containing enzymes. It presents within <strong>3 years</strong> of age and is characterized by:</p>\n<ul>\n<li>Depigmented kinky hair</li>\n<li>Failure to thrive</li>\n<li>Neurodegenerative symptoms like loss of developmental milestones, truncal hypotonia, epilepsyLoose, wrinkled skin</li>\n<li>Multiple fractures</li>\n<li>Poor visual acuity</li>\n<li>Recurrent infections.</li>\n</ul>\n<p>Lab investigations show <strong>low serum copper&nbsp;</strong>(&lt;65 &mu;g/dL) and <strong>low ceruloplasmin</strong>(&lt;20 mg/dl). The disease is fatal as it has no curative treatment. But, administration of <strong>L-histidine</strong> and <strong>copper chloride</strong> injections may be beneficial, if started early.</p><p><strong>Aceruloplasminemia</strong> is an <strong>autosomal recessive</strong> disease characterized by tissue <strong>iron overload</strong>, mental deterioration, <strong>microcytic anemia</strong>, and <strong>low serum iron</strong> and <strong>copper</strong> concentrations.<br /><br />Option B: <strong>Low serum copper</strong>&nbsp;and <strong>low ceruloplasmin</strong> is also seen in <strong>Wilson&rsquo;s disease</strong>, but is associated with the gene defect <strong>ATP7B</strong>&nbsp;on <strong>chromosome 13</strong>. It&nbsp;is an <strong>autosomal recessive</strong> disorder of copper metabolism with features of hepatolenticular degeneration and <strong>Kayser Fleischer ring</strong>.&nbsp; &nbsp;</p>\n<p>Option A: <strong>Dubin Johnson Syndrome</strong> is an <strong>autosomal recessive</strong> disorder characterized by impaired canalicular excretion of bilirubin due to mutation in <strong>MRP-2 protein</strong> leading to <strong>conjugated hyperbilirubinemia</strong>.&nbsp;</p>\n<p>Option D: <strong>Gilbert&rsquo;s Syndrome</strong> is characterized by <strong>decreased UDP glucuronyl transferase</strong> activity leading to <strong>unconjugated hyperbilirubinemia</strong>, which can be <strong>autosomal recessive</strong> or<strong> dominant</strong>.</p><hr><h3>Related Pearl: Menkes disease</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3f0c58fe358940b393c96afe12ef3455x1280x1951.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2513",
      "difficulty": "easy"
    }
  ]
}